Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Hospira Sues B. Braun Over Infusion-Pump System Patents

Hospira Inc., a maker of acute-care products, sued a U.S. unit of Germany’s B. Braun Melsungen AG alleging infringement of patents for drug-infusion pump technology.

B. Braun Medical Inc., based in Bethlehem, Pennsylvania, is using inventions that belong to Hospira, of Lake Forest, Illinois, by making and selling its drug-delivery systems without permission, Hospira contends in a complaint filed yesterday in federal court in Wilmington, Delaware.

“Hospira is the owner of the entire right, title and interest” in the patents, and Braun should pay damages for lost profits and legal fees and be prohibited from its wrongful actions after a jury trial, plaintiff’s lawyers said in court papers.

Hospira itself was sued in New York Federal court in February over a canceled influenza-vaccine supply contract by GlaxoSmithKline Plc., which questioned the quality of the product. The case is continuing.

Jason Ford, a B. Braun spokesman, didn’t immediately reply to voice and e-mail requests for comment on the patent action.

The case is Hospira Inc. v. B. Braun Medical Inc., 13-cv-00819, U.S. District Court, District of Delaware (Wilmington).

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.